SynthesisFrontiers in pharmacology2022

Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review.

Vivien Kin Yi Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.